Trial NCT04779151

View at ClinicalTrials.gov 
Org. Study IDs: 2020-002766-14
Secondary IDs: 2020/3093

Last trial update was posted on 2024-03-26

MeSH Interventions

Dostarlimab Niraparib

MeSH Conditions

Adenocarcinoma Biliary Tract Neoplasms Carcinoma, Renal Cell Hypersensitivity Urinary Bladder Neoplasms

Other Conditions

Biliary Tract Cancer Clear Cell Renal Cell Carcinoma Gastric Adenocarcinoma Gastro-oesophageal Adenocarcinoma Head and Neck Cancer Pancreatic Ductal Adenocarcinoma Platinum-sensitive Urothelial Bladder Cancer Urothelial Bladder Cancer

Stopping Reasons

Abandon by GSK

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID